Supplemental tables and figures of 'Tirzepatide immunogenicity on pharmacokinetics, efficacy, and safety: analysis of data from Phase 3 studies'
Published: 23 August 2023| Version 1 | DOI: 10.17632/dxthnf38zx.1
Contributors:
, Michael E. Hodsdon, Ying Grace Li, Greg Anglin, Shweta Urva, Karen Schneck, Jennifer N. Bardos, Ricardo Fonseca Martins, Katelyn Brown, Boris CalderonDescription
Supplemental tables and figures of 'Tirzepatide immunogenicity on pharmacokinetics, efficacy, and safety: analysis of data from Phase 3 studies'
Files
Categories
Immunogenicity, Clinical Trial Results
Funding
Eli Lilly and Company